Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Rudolf A Jörres (Munich, Germany), Tanja Lucke, Ronald Herrera, Margarethe Wacker, Rolf Holle, Frank Biertz, Dennis Nowak, Rudolf Maria Huber, Sandra Söhler, Claus Vogelmeier, Joachim Ficker, Harald Mückter, Rudolf A. Jörres. Systematic analysis of self-reported comorbidities in the COSYCONET COPD cohort study by stepwise evaluation of medication. Eur Respir J 2016; 48: Suppl. 60, 1121

Member's Comments

No comment yet.

Related content which might interest you: COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014 Costs and effects of structured COPD care – An observational, matched-cohort study Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013 COPD severity analysis according to current evaluation criteria – National survey Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Patient-reported outcomes as predictors of COPD exacerbations - a prospective study Source: International Congress 2014 – COPD markers Year: 2014 Comorbidities and burden of COPD: A population based case-control study Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Comorbidities, gender-differences and COPD severity: The French Palomb cohort Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Co-morbidities of adult smokers at risk of COPD evaluated in a 6-year prospective study Source: International Congress 2015 – COPD: notable points Year: 2015 Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 Comorbidities and COPD severity: The French Palomb cohort Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Prevalence and predictors of electronic cigarette use by patients with COPD in the Birmingham COPD cohort Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014 Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 COPD specific comorbidities: A prospective, objective and controlled evaluation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015